Faeth Therapeutics, a healthcare company developing machine learning-driven precision nutrition solutions and therapeutic regimens to treat cancer, announced the appointment of Endocrine Society member Thomas Strack, MD, as chief medical officer. Strack brings more than 29 years of biopharmaceutical industry and has led all phases of clinical development. Strack previously served as senior vice president,...
Author: Mark Newman
Endocrine Society Speaks Out Against Texas Governor’s Anti-Transgender Directive
On Monday, February 21, the Texas attorney general issued a nonbinding legal opinion arguing that gender-affirming care falls under the state’s existing definition of child abuse and neglect. Following this, Texas Governor Greg Abbott released a directive ordering the Texas Department of Family and Protective Services (DFPS) to conduct investigations of any reported instances of...
Black People with Diabetes Disproportionately Affected by Diabetic Ketoacidosis During COVID
Black people with diabetes were more likely to develop cases of a life-threatening complication called diabetic ketoacidosis during the pandemic, even in people without COVID-19, according to a new study from the T1D Exchange published in The Journal of Clinical Endocrinology and Metabolism. People with diabetes are more likely to get extremely sick from COVID-19,...
Dynamic Duo: Talking with the Editors of a New Book on Endocrine Diseases in Pregnancy
Nadia Barghouthi, MD, MPH, (near right) and Jessica Perini, MD, MS, colleagues in the Department of Endocrinology and Metabolism at West Virginia University School of Medicine, talk to Endocrine News about their new book, Endocrine Diseases in Pregnancy and the Postpartum Period, what they discovered while researching it and who needs this book in their...Babies Exposed to Cannabis in the Womb May Be at Risk for Obesity, High Blood sugar
Both CBD and THC put children at risk despite CBD being marketed as having health benefits. Cannabis use among pregnant women is on the rise and may be associated with negative health outcomes in children, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism. A 2016 study in...
Endocrine Society Applauds House for Taking Action to Improve Insulin Affordability
Underlying problem of rising insulin prices still needs to be addressed. The Endocrine Society applauds the House of Representatives for hearing our call to improve insulin affordability for people with diabetes as it prepares to vote on the Affordable Insulin Now Act this week. The bill would cap patients’ out-of-pocket insulin costs to $35 per month for people on Medicare and private...
Following intense negotiations, in March the House and Senate finally passed an appropriations package that funded the federal government for Fiscal Year (FY) 2022, which technically began October 1, 2021. The $1.5-trillion package received bipartisan support and follows months of advocacy by the Endocrine Society with increased funding for our priorities. The bill includes several important...
Past President William F. Young, Jr., will serve as inaugural Editor-in-Chief. The Endocrine Society announced it will launch a new open access, online-only journal featuring reports on clinical cases and clinical problem solving from across the field of endocrinology. JCEM Case Reports will be fully peer-reviewed and begin publishing issues in late 2022. Society Past...